TEAS Plus New Application

ELAN

Summa Therapeutics, LLC

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 98089191
Filing Date: 07/18/2023

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK Elan
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT Elan
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Summa Therapeutics, LLC
INTERNAL ADDRESS 2nd floor
*MAILING ADDRESS 225 Dyer St.
*CITY Providence
*STATE
(Required for U.S. applicants)
Rhode Island
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02903
PHONE 4014841355
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE LIMITED LIABILITY COMPANY
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Delaware
OWNER DOMICILE ADDRESS(NEW)
*ADDRESS XXXX
*CITY XXXX
*STATE
(Required for U.S. applicants)
XXXX
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY XXXX
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
XXXX
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 010 
*IDENTIFICATION Catheters
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
CORRESPONDENCE INFORMATION
NAME Summa Therapeutics, LLC
DOCKET/REFERENCE NUMBER 20230718.01
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmurphy@summatherapeutics.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) 101blackstoneboulevard@gmail.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Timothy Murphy/
* SIGNATORY'S NAME Timothy Murphy
* SIGNATORY'S POSITION CEO
SIGNATORY'S PHONE NUMBER 401-484-1355
* DATE SIGNED 07/18/2023
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 98089191
Filing Date: 07/18/2023

To the Commissioner for Trademarks:

MARK: Elan (Standard Characters, see mark)
The literal element of the mark consists of Elan. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Summa Therapeutics, LLC, a limited liability company legally organized under the laws of Delaware, having an address of
      2nd floor
      225 Dyer St.
      Providence, Rhode Island 02903
      United States
      4014841355(phone)
      XXXXand a domicile address of       XXXX
      XXXX, XXXX XXXX
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 010:  Catheters
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).


The applicant's current Correspondence Information:
      Summa Therapeutics, LLC
       PRIMARY EMAIL FOR CORRESPONDENCE: tmurphy@summatherapeutics.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): 101blackstoneboulevard@gmail.com
The docket/reference number is 20230718.01.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Timothy Murphy/   Date: 07/18/2023
Signatory's Name: Timothy Murphy
Signatory's Position: CEO
Signatory's Phone Number: 401-484-1355
Signature method: Signed directly within the form
Payment Sale Number: 98089191
Payment Accounting Date: 07/18/2023

Serial Number: 98089191
Internet Transmission Date: Tue Jul 18 09:00:51 ET 2023
TEAS Stamp: USPTO/FTK-XXXX:XXX:XX:XXXX:XXXX:XXXX:XXX
X:XX-20230718090052555804-98089191-8601a
52fa3ce9eb79e24d9aba8397675ddada9a66ac4a
18bb16aab18b1ebf56c-CC-00518706-20230718
085119617036

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed